Explainer

Explainer: How come some AstraZeneca vaccine recipients develop blood clots

Andrew Brown
By Andrew Brown
Updated April 15 2021 - 5:13am, first published April 14 2021 - 6:00pm
Advice was changed for the AstraZeneca vaccine in Australia due to the blood-clotting risk. Picture: Karleen Minney

The small risk of patients developing a rare blood-clotting condition after receiving a dose of the AstraZeneca vaccine has led to a major roadblock and delay for Australia's rollout of the COVID jab.

Advertisement

Ad

Advertisement

Ad

Advertisement

Ad

Advertisement

Ad

Advertisement

Ad
Andrew Brown

Andrew Brown

Journalist

I've been part of the Canberra Times since 2016, after reporting at local papers in Sydney's north-west. Since starting at the paper I've had stints on the Sunday Times, on the early morning breaking news round, and now as a general reporter, covering the ins and outs of anything and everything happening in Canberra, with a focus on health.

Get the latest Wagga Wagga news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.